Mineral bone disorders are usually the consequence of electrolyte imbalances, i.e., hyperphosphatemia, hyperkalaemia, or hypercalcemia (Navarro-García et al., 2018), which have been associated with high plasma levels of FGF-23. This evidence concerns the gene FGF23 and abnormal mineralization disorder.